Pharmaceutical

Kronos Bio announces interim CEO and workforce cuts of 83%

Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective 3 December.

Nov 29, 2024 - 06:00
Kronos Bio announces interim CEO and workforce cuts of 83%
Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective 3 December.
Read the original article

Tags:

Previous Article

Advanz Pharma’s liver disease drug pulled from European market after court hearing

Next Article

Trump agency nominations show pharma industry as divided as US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

‘We fail people’: New data on disparities in Medicaid access to opioid addiction treatment

‘We fail people’: New data on disparities in Medicaid a...

Jun 24, 2023

INV-347 by Inversago Pharma for Obesity: Likelihood of ...

Feb 20, 2024

Opinion: STAT+: The PATCH Act’s approach to securing medical devices actually gives malicious actors a blueprint

Opinion: STAT+: The PATCH Act’s approach to securing me...

Nov 7, 2023